Volume 11, Number 8—August 2005
Dispatch
Cost-Benefit of Stockpiling Drugs for Influenza Pandemic
Ran D. Balicer*†
, Michael Huerta*, Nadav Davidovitch*†, and Itamar Grotto*†
, Michael Huerta*, Nadav Davidovitch*†, and Itamar Grotto*†Table A2
Cost and benefit parameters included in the model
| Variable | Point estimate (US$) | Reference |
|---|---|---|
| Average daily wage* | 71.6 | 14 |
| Cost of hospital day* | 317.8 | 14 |
| Cost of physician visit*† | 45.3 | 17 |
| Antiviral (NAI) drug costs‡ | ||
| 5-day therapeutic course | 8.9 | Roche, pers. comm. |
| 7-day prophylactic course | 6.2 | Roche, pers. comm |
*Converted from original prices in NIS (new Israeli shekels) at the rate of US$1 = 4.50 NIS.
†Physician costs include prescription drugs and diagnostic tests.
‡NAI, neuraminidase inhibitors. Based on manufacturer's quoted price for oseltamivir.
